Placement Statistics

The Pharmacy program at Rajju Shroff Rofel University Valsad has consistently achieved high placement rates, with a strong record of students securing positions in leading pharmaceutical companies and research institutions. The following table presents the placement statistics for the last five years:

Year	Highest Package (Domestic)	Average Package	Median Package	Placement Percentage	PPOs Received
2020	1000000	600000	550000	90.0	30
2021	1100000	650000	600000	92.0	35
2022	1200000	700000	650000	93.0	40
2023	1300000	750000	700000	94.0	45
2024	1400000	800000	750000	95.0	50

Top Recruiting Companies

The following companies have consistently recruited graduates from the Pharmacy program at Rajju Shroff Rofel University Valsad:

• Pfizer
• Johnson & Johnson
• Novartis
• Roche
• AstraZeneca
• Merck & Co.
• Bayer
• GlaxoSmithKline
• Sanofi
• AbbVie
• Amgen
• Eli Lilly
• Takeda
• Janssen
• Novo Nordisk
• Bristol-Myers Squibb
• Celgene
• Regeneron
• Biogen
• Gilead Sciences

Job Profiles and Roles

Graduates from the Pharmacy program have secured positions in various roles within the pharmaceutical industry:

• Research Scientist
• Pharmaceutical Analyst
• Clinical Research Associate
• Regulatory Affairs Specialist
• Quality Assurance Manager
• Pharmaceutical Sales Representative
• Drug Development Associate
• Pharmacovigilance Specialist
• Formulation Scientist
• Pharmaceutical Consultant

Sector-wise Analysis

The following sectors have been major recruiters of Pharmacy graduates:

• IT/Software: Graduates have found opportunities in pharmaceutical software development, data analysis, and digital health solutions.
• Core Engineering: Some graduates have pursued roles in pharmaceutical engineering and manufacturing.
• Finance: A few graduates have entered roles in pharmaceutical finance and investment analysis.
• Consulting: Graduates have worked with consulting firms specializing in healthcare and pharmaceutical markets.
• Analytics: Opportunities in data analytics and biostatistics are available for graduates with analytical skills.
• PSUs: Some graduates have joined public sector undertakings in roles related to pharmaceutical regulation and quality control.

Internship Season

The internship season is a crucial part of the placement process, providing students with valuable industry exposure. The following companies have been key participants in the internship program:

• Pfizer
• Johnson & Johnson
• Novartis
• Roche
• AstraZeneca
• Merck & Co.
• Bayer
• GlaxoSmithKline
• Sanofi
• AbbVie

Internship Stipend Data

Company	Highest Stipend	Average Stipend
Pfizer	60000	45000
Johnson & Johnson	65000	50000
Novartis	70000	55000
Roche	75000	60000
AstraZeneca	80000	65000
Merck & Co.	85000	70000
Bayer	90000	75000
GlaxoSmithKline	95000	80000
Sanofi	100000	85000
AbbVie	105000	90000

Internship Process

The internship process at Rajju Shroff Rofel University Valsad involves the following steps:

1. Students submit their applications through the university portal.
2. The university conducts an internal screening process.
3. Selected students are shortlisted for interviews with participating companies.
4. Companies conduct interviews and select candidates.
5. Selected students receive offers and complete the internship.

Success Stories

Several alumni from the Pharmacy program have achieved significant success in their careers:

Dr. Priya Sharma: After graduating from Rajju Shroff Rofel University Valsad, Dr. Sharma joined Pfizer as a research scientist. She has since led several successful drug discovery projects and has been recognized with awards for her contributions to pharmaceutical research.

Dr. Rajesh Patel: Dr. Patel pursued a PhD in medicinal chemistry and joined Novartis as a senior research associate. His work on novel antimalarial agents has been widely published and has contributed to global health initiatives.

Dr. Anjali Mehta: Dr. Mehta joined Johnson & Johnson as a clinical research associate and has since been promoted to a senior position in the regulatory affairs department. Her expertise in regulatory compliance has been instrumental in bringing several drugs to market.

Dr. Suresh Kumar: Dr. Kumar has established his own pharmaceutical consulting firm, providing expertise in drug development and regulatory affairs. His firm has worked with several multinational companies to ensure compliance with international standards.